The Role of Cryoablation in Breast Cancer Beyond the Oncologic Control: COST and Breast-Q Patient-Reported Outcomes
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
https://link.springer.com/content/pdf/10.1245/s10434-022-12570-5.pdf
Reference35 articles.
1. National Comprehensive Cancer Network. Breast cancer (version 2.2022). 2022. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed 22 Mar 2022.
2. Curigliano G, et al. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2017;28(8):1700–12.
3. Roubidoux MA, et al. Small (< 2.0-cm) breast cancers: mammographic and US findings at US-guided cryoablation—initial experience. Radiology. 2004;233(3):857–67.
4. Habrawi Z, et al. Cryoablation: a promising non-operative therapy for low-risk breast cancer. Am J Surg. 2021;221(1):127–33.
5. Fine RE, et al. Cryoablation without excision for low-risk early-stage breast cancer: 3-year interim analysis of ipsilateral breast tumor recurrence in the ICE3 trial. Ann Surg Oncol. 2021;28(10):5525–34.
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Screening for Financial Toxicity Among Patients With Cancer: A Systematic Review;Journal of the American College of Radiology;2024-09
2. Acceptance and results of cryoablation for the treatment of early breast cancer in non-surgical patients;British Journal of Radiology;2024-07-29
3. Cryoablation of Primary Breast Cancer in Patients Ineligible for Clinical Trials: A Multiinstitutional Study;American Journal of Roentgenology;2024-07-10
4. Cancer cost-related subjective financial distress among breast cancer: a scoping review;Supportive Care in Cancer;2024-07
5. Percutaneous ultrasound-guided cryoablation for early-stage primary breast cancer: a follow-up study in Japan;Breast Cancer;2024-04-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3